grant

Cell Type Specific Transcriptional Cascades in Inner Ear Development

Organization UNIVERSITY OF MARYLAND BALTIMORELocation BALTIMORE, UNITED STATESPosted 1 Mar 2015Deadline 30 Nov 2026
NIHUS FederalResearch GrantFY2025Active Follow-upAddressAgeBasal Transcription FactorBasal transcription factor genesBioinformaticsBiologicalBrachydanio rerioCandidate Disease GeneCandidate GeneCell BodyCell Communication and SignalingCell DifferentiationCell Differentiation processCell FunctionCell MaturationCell PhysiologyCell ProcessCell SignalingCell SurvivalCell ViabilityCellsCellular FunctionCellular PhysiologyCellular ProcessCellular biologyCochleaCochlear OrganCommunitiesCompensationCorti CellDanio rerioDataData SetDefectDevelopmentDisablingDiseaseDisorderEarEmbryoEmbryonicEpidemicEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEquilibriumEquilibrium Hair CellFundingFutureGFI-1GFI1GFI1 geneGFI1AGene ExpressionGene Expression MonitoringGene Expression Pattern AnalysisGene Expression ProfilingGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGenesGeneticGenetic TranscriptionGenetic studyGenetics-MutagenesisGenomicsGoalsGrantHairHair CellsHearingHourHumanInformaticsInternal EarInternationalInterventionIntracellular Communication and SignalingInvestigatorsKO miceKnock-out MiceKnockout MiceKnowledgeLabyrinthLeadLettersMaintenanceMapsMiceMice MammalsModelingModern ManMolecularMurineMusMutagenesisMutagenesis Molecular BiologyNamesNoise-Induced Hearing LossNull MouseOuter Hair CellsPathologyPathway interactionsPb elementPhenotypePlayPopulationPresbyacusisPresbycusisProcessProductionProgenitor CellsProtocolProtocols documentationRFX1RNA ExpressionRegulator GenesResearchResearch PersonnelResearchersRiboTagRoleRouteRunningSensorySensory HairSignal PathwaySignal TransductionSignal Transduction SystemsSignalingSubcellular ProcessTestingTherapeutic InterventionTranscript Expression AnalysesTranscript Expression AnalysisTranscriptionTranscription Factor Proto-OncogeneTranscription factor genesTranscriptional Regulatory ElementsVestibularVestibular Hair CellsVisualizationWorkZebra DanioZebra FishZebrafishactive followupage associated hearing lossage induced hearing lossage related decline in hearingage related hearing deficitsage related hearing impairmentage related hearing lossagesaging associated hearing lossaging induced hearing lossaging related decline in hearingaging related hearing deficitsaging related hearing impairmentaging related hearing lossanalyze gene expressionbalancebalance functionbiologicbiological signal transductioncandidate identificationcell biologycell typecellular differentiationciliogenesiscilium biogenesisconditional knock-outconditional knockoutdesigndesigningdevelopmentalear hair cellepigeneticallyfollow upfollow-upfollowed upfollowupgene expression analysisgene expression assaygenetic trans acting elementhair cell regenerationhearing loss therapyhearing loss treatmentheavy metal Pbheavy metal leadinner earinner ear developmentintervention therapymolecular targeted therapeuticsmolecular targeted therapiesmolecular targeted treatmentmouse modelmultiomicsmultiple omicsmurine modelnamenamednamingnoise related hearing lossnoise-induced hearing impairmentnovelpanomicspathwaypostnatalpreventpreventingprogenitor cell fateprogenitor fateprogramsregeneration based therapyregeneration therapyregenerative therapeuticsregenerative therapyregulatory genesocial rolestem and progenitor cell fatestem cell fatestem cellssuccesstooltrans acting elementtranscription factortranscriptional profilingtranscriptomicstranslatometreatment for hearing lossvestibular system
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Disabling age-related hearing loss (ARHL) afflicts greater than 50% of the population over the age of 70.
The progressive loss of sensory hair cells (HCs) of the cochlea, primarily the outer HCs (OHCs), is either the

cause or the final common pathology of most forms of ARHL. However, the molecular basis of ARHL is

unknown, impeding development of targeted interventions. Furthermore, attempts to reprogram progenitor

cells towards cochlear HC fates result primarily in immature HC-like cells, similar to vestibular HCs. For these

reasons, the study of the molecular pathways underlying OHC differentiation and survival is critical.

Transcription factors (TFs) are key regulators of gene expression. When associated with disease,

identifying the upstream regulators and downstream targets of a TF is an effective route to determine

additional key players in the same process. In this competitive renewal we build upon our previous success,

identifying critical roles for the RFX and IKZF2 TFs in OHC differentiation, function and survival, and follow up

with two specific aims designed to elucidate their molecular mechanism within the HC/OHC genetic programs:

Group 1 RFX TFs (RFX1/2/3), are master regulators of ciliogenesis. However, while OHCs lacking Rfx1/3

die within 12 hours from the onset of hearing, they have normal bundle development. RFX2 is transiently

expressed in the developing HCs, possibly preventing a ciliogenesis defect with loss of Rfx1/3. We therefore

hypothesize that group 1 RFX TFs have a dual role in HC development, with an early role in hair bundle

formation, and later role in terminal differentiation and survival. Specific Aim 1: To identify the mechanisms by

which RFX TFs support embryonic as well as early post-natal cochlear hair cell differentiation.

IKZF2 is a key regulator of OHC gene expression, precisely regulated to express only in OHCs starting

from P4. We hypothesize that: (1) deletion of IKZF2 target genes will reveal genes essential for OHC function

and survival; (2) IKZF2 is required for maintenance of mature OHCs; and (3) Ikzf2 expression is regulated by a

master-regulator of OHC maturation. Specific Aim 2: To identify the mechanism by which IKZF2 leads to OHC

differentiation, to determine its role in mature OHCs, and to identify its upstream regulatory network.

To accomplish these aims we combine novel protocols for OHC-specific multi-omic analyses with state-

of-the-art bioinformatics, and characterization of novel mouse models to validate the roles of candidate genes

in hearing. Successful completion of these aims will: (1) impact our understanding of OHC differentiation and

survival; (2) functionally characterize the roles of key RFX and IKZF2 target genes in hearing; (3) result in

transcriptomic and epigenetic maps of differentiating and mature OHCs which will be applied to inform

studies for HC regeneration/identifying candidate genes for ARHL; and (4) generate numerous mouse models

for RFX and IKZF2 target genes, which will be readily available to the scientific community. Additionally, all of

the data generated as part of this proposal will be shared via the gEAR (umgear.org).

Grant Number: 5U01DC013817-10
NIH Institute/Center: NIH

Principal Investigator: Zubair Ahmed

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →